Ingeniatrics

In this new position Javier will have two entwined missions: the responsibility of handling daily technical relationship between Ingeniatrics Technology (Spain) and Ingeniatrics Global (USA); providing at the same time a pres-sales scientific support in those Key International Accounts he is commended like Beiersdorf, Proter & Gamble, Wella, just to mention a few ones.

Ingeniatrics Group envisions ways to improve our quality of life through innovative technology, to this goal it is creating a human capital recruiting those able to take Flow Focusing and Flow Blurring into real, tangible benefits.

Javi’s career started out as plants analyst: biological reactor oxygenation systems; going through a position as laboratory technician: building materials experiments. Soon, he got acquainted with cutting-edge technology stepping ahead to more ambitious projects: in the Flow Mechanics and Aerospatial Engineering Department, under the direction of Alfonso Ganan-Calvo – discoverer of Flow Focusing, he carried out research on particles for microencapsulated food additives development and worked in the development of a brand-new automatic apparatus for teeth prosthesis coating, Noricum.

Ingeniatrics CEO Joaquin Gomez told this broad background on applied Microfluidics made Javi the right candidate to keep the best connection between the American and the Spanish “sides” of the team and to help developing new businesses.

Ingeniatrics is enriching its human capital with professionals knowledgeable on microfluidics technology, even acquainted from the beginning of their careers with the study of Flow Focusing technology and its increasing scope.

Jorge López Serrano main professional traits are his continued involvement as a member of the Aerospace Engineering and Flow Mechanics Department on microfluidic technologies projects, i.e. “Study and development of methods, physics, and design of devices for multiple capillary jets production applied to soft and controlled cell encapsulation”. His contribution to the project “biotechnology applied to the development of new diagnostic tools and rare diseases prognosis” and the “study and development of applications, methods, physics and design of devices for the generation of capillary jets and production of micro and nanometric particles, aerosols and foams” was vital. That places him in a unique position in terms of Flow Focusing devices design, manufacturing and quality control.

All through his continually progressing career he has played a part in key projects: "Novel Flow Focusing technology to produce microencapsulated probiotic bacteria for the food sector" or the project: "Development and integration of microfluidic microsystems (MEMS), for the production of simple and complex microparticles using Flow Focusing and ElectroFlow Focusing ".

His mission in the Department of Engineering and Production of Ingeniatrics Technologies is the design and manufacturing of innovative products to revolutionize the microencapsulation world by means of multiplexing existing systems. He will also be in charge of increasing production as Ingeniatrics Technologies is becoming a technologically advanced equipment manufacturer: CellENA cell microencapsulation portable device, OneNeb analytic nebulizer for Agilent Technologies and Frialia-model nozzles for its distributor Frialia Microclimas.

Ingeniatrics Technologies CEO Joaquin Gomez’s words have been: "We focus on skilled human capital as the first bridge towards our mission, what is to translate the most innovative engineering on added value for the benefit of the society. Coming a manufacturer, Ingeniatrics enters a new stage; Jorge is going to be a main pillar for his ability at the time of accurately making concepts come tangible objects".

Immunostep is a technological company highly specialized on production of antibodies, reagents and other streamlined products for Flow Cytometry. Flow Cytometry is mainly utilized to recount and sort out microorganisms or cellules in hospitals, for clinical purposes and research laboratories. United Nations selected Immunostep as far as 2006 for supplying these kind of products.

During 2010, Immunostep has concluded the development and marketing study of a brand-new tube containing fluorescent microcapsules of a given caliber, to check results and collection in a Flow Cytometry apparatus. The mechanics involved in the manufacturing of this new Immunostep product require high precision and extremely well tuned control. All the microcapsules have to be of even diameter and the output should not damage them in any way, that’s why Immunostep chose Flow Focusing technology and Ingeniatrics as supplier.

Flow Focusing technology allows an accurate control of diameter and monodispersion, that all the microcapsules produced are even. Ingeniatrics was founded by a group of scientists working at the University of Seville led by Alfonso Ganan, the discoverer of Flow Focusing phenomenon. As from July 1st, Ingeniatrics is producing these tubes, which is its first production of a completely finished product to Pharma industry.

Right to left, Mercedes Fernandez Arevalo, vicedean of the University of Seville and Head of the Group of Pharmaceutical Technology; Joaquin Gomez, Ingeniatrics’ CEO; Elena Ogalla researcher at Ingeniatrics; Lucia Martin, at the same time researcher at University of Seville and one of Ingeniatrics shareholders; with Maria Angeles and Josefa Martin, members of Mercedes’ team.

Joaquin Gomez Moya, CEO at Ingeniatrics, visited on Monday 5th the facilities of the Group of Pharmaceutical Technology at the University of Seville. This group is led by Mercedes Fernandez Arevalo, vicedean of the University, and has achieved outstanding results in microencapsulation of insulin, for diabetes, and cannabinoids, for pain treatment, among other areas. Now they head towards further co-operation.

Flow Focusing has demonstrated advantageous at medicament microencapsulation for it improves monodispersion, all the microcapsules are of even diameter, is usable for many products and different sizes in the range from one micron to several hundreds micra, and allows a careful handling of said microcapsules.

Mercedes envisions the possibility of extending current cooperation. Nowadays Ingeniatrics affords Mercedes’ group the utilization of its nozzles within research and academic projects. But there’s the possibility that Pharmaceutical Technology Group starts servicing customers what have displayed interest on the Group medicament microencapsulation achievements.

Ingeniatrics Technologies is a world leading company in the field of Flow Focusing microencapsulation and other developments within microfluidics field. It was founded by a group of scientists of the University of Seville on 2001 and recently hired Joaquin Gomez with a view to dramatically scale up its production capacity and to launch its services and brands internationally.

Piotr Garstecki, first by the left, renowned scientist in the ICPh with some collaborators. Jacek Michalski one of ICPh’s experts on automation. Marcin Izydorzak, director of the Institute’s spin-off Scope microfluidics is the third one. Monika is a researcher at ICPh.

Robert Hołist, deputy director of ICPh, Piotr Garstecki, one of the world leading researchers in microfluidics and Martin Izydorzak, director of Scope Microfluidics received Ingeniatrics’ CEO Joaquin Gomez Moya during his visit to Warsaw. Both entities have started talks to collaborate on grounds of complementary fields of expertise to compete in microfluidics technology tough global market.

From June 28th to July 2nd Joaquin Gomez stayed visiting the modern facilities of the Institute of Physical Chemistry, part of the Polish Academy of Sciences. ICPh has steadily been increasing its publishing of papers on fields such as material characterization, microfluidics and catalysis during the last ten years. Alfonso Gañán, founder of Ingeniatrics, and its group at the University of Seville were already cooperating on academic projects with Piotr Garstecki’s group at Warsaw on state-of-the-art Flow Focusing research. Now, ICPh principals look for strategic partners to step ahead in its strategy to gain better access to international customers interested on its expertise in engineering, automation and technological integration.

In Joaquin Gomez’s words, “there are complementary fields of expertise and largely interesting cooperation opportunities between us. The ICPh know-how could help us to dramatically increase our efficiency and response to our current customers. We look at this chance as a long-term relationship; fortunately they share our international scope.

Microfluidics science and markets are global; if we European companies and institutions want to successfully compete in such environment, it makes no sense that we stay limited to an old fashioned national approach. We do need reliable partners like ICPh to profit potential synergies. Our experience cooperating with University of Seville, but as well with other institutions like Universities of Vitoria, Alicante and Cadiz has been wonderful so far. In this path, international partnership is the natural next step.”

Ingeniatrics Technologies is one of the world leaders in carrying out Research, Development and Engineering on Flow Focusing microencapsulation and Flow Blurring spraying.

William Aulet, Managing Director at MIT Entrepreneurial Center.

During MIT’s Delegation stay in Seville they visited the most relevant innovative companies and university spin-offs – Ingeniatrics amongst them, on Monday 21st -. The Entrepreneurship Capacity Assessment Team, ECAT, is led by William Aulet, head of the MIT Entrepreneur Center, MITEC, and expects to attain firsthand data on Andalucia innovation ecosystem.

Massachusetts Institute of Technology is well known for very likely the most part of living Nobel-awarded scientists works at the MIT. Were MIT and its spin-off companies a country economy, it would be one the 20 biggest in the planet.

William Aulet’s multidisciplinary ECA Team encompasses a wide range of technological knowledge and is integrated by five experts on technology transference: William Aulet himself being knowledgeable on Management, Mercedes Delgado-García on Strategy and Competitiveness, Fiona E. Murray on Innovation, Scott Stern on Strategy, all of them linked to famous MIT Sloan School of Management, and Christopher Walti on Business Management. Mr. Stern and Mrs. Delgado were member of Michel Porter’s team in a study on industry clusters. William and Christopher visited Ingeniatrics to conduct a thorough interview on key success factors and constrains for innovative entrepreneurship at Andalucia, and about Ingeniatrics case specifically.

They have been received by regional government ministry representatives and showed to a number of innovative companies. At Ingeniatrics, they were received by Alfonso Ganan, chairman, Angel Cebolla vice-president and Joaquin Gomez Moya, CEO, who emphasized the bond between Ingeniatrics and the University of Seville.

MITEC has targeted five regions in the world where its Clean Technology Research Center could be settled. Andalucia advantages to be chosen for any foreign direct investment were highlighted by last fDi Magazine – Financial Times group - European Cities & Regions of the Future 2010/11 Report.

Ingeniatrics Technologies owns a 50-patents portfolio and was founded on 2001 by a Spaniard scientists group led by Alfonso Ganan who has been recently appointed Chairman. Ingeniatrics is running a number of relevant changes in few months. It has appointed Joaquin Gomez Moya as CEO and General Manager. Ingeniatrics is about to launch its user-friendly Flow Focusing microencapsulation device, Cell-ENA. Lately, other significant milestones were the achievement of a global agreement with Varian Inc., Melbourne, now Agilent Technologies, to integrate its analytic nebulizer OneNeb as part of its ICP technology equipment. And the foundation of Ingeniatrics Global LLC, a US headquartered Joint Venture to exploit potential fields of Flow Blurring and Flow Focusing technologies.